A detailed history of David J Yvars Group transactions in Novo Nordisk A S stock. As of the latest transaction made, David J Yvars Group holds 31,838 shares of NVO stock, worth $3.44 Million. This represents 2.42% of its overall portfolio holdings.

Number of Shares
31,838
Previous 31,215 2.0%
Holding current value
$3.44 Million
Previous $4.46 Million 14.93%
% of portfolio
2.42%
Previous 2.88%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$119.07 - $145.42 $74,180 - $90,596
623 Added 2.0%
31,838 $3.79 Million
Q2 2024

Jul 22, 2024

BUY
$122.71 - $146.91 $22,210 - $26,590
181 Added 0.58%
31,215 $4.46 Million
Q1 2024

Apr 11, 2024

BUY
$102.11 - $135.92 $292,238 - $389,003
2,862 Added 10.16%
31,034 $3.98 Million
Q4 2023

Jan 09, 2024

BUY
$87.78 - $105.45 $2.47 Million - $2.97 Million
28,172 New
28,172 $2.91 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track David J Yvars Group Portfolio

Follow David J Yvars Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of David J Yvars Group, based on Form 13F filings with the SEC.

News

Stay updated on David J Yvars Group with notifications on news.